EUTM file information

014373807

ZALABIV

July 16, 2015

Trademark Summary

The trademark application ZALABIV was filed by Amgen Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on September 7, 2015, and it was registered by office on December 15, 2015 without any oppositions.

The application was filed in Dutch (English was selected as the second language).

The renewal of the trademark was recorded by the office on December 18, 2024.

Change of name and professional address of the trademark registration was recorded on November 5, 2023.

Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceutical preparations
    2. Pharmaceutical preparations used for the treatment of parathyroid, glandular and hormone disorders
    3. Pharmaceutical preparations used for the treatment of renal and kidney disorders.